Clinical Predictive Value of the in Vitro Cell Line, Human Xenograft, and Mouse Allograft Preclinical Cancer Models
作者： Theodora Voskoglou-Nomikos , Lesley Seymour , Joseph L. Pater
DOI:
关键词:
摘要: … responses than publication of Phase II trials or of preclinical cancer model experiments. … tumor cell line and the human xenograft models might have good clinical predictive value in …
aacrjournals.org
researchgate.net 参考文章(58)
G P Canellos, R C Knapp, L M Parker, R A Yankee, C T Griffiths, High-dose methotrexate with leucovorin rescue in ovarian cancer: a phase II study. Cancer treatment reports. ,vol. 63, pp. 275- 279 ,(1979)
Jerald J. Killion, Robert Radinsky, Isaiah J. Fidler, Orthotopic models are necessary to predict therapy of transplantable tumors in mice Cancer and Metastasis Reviews. ,vol. 17, pp. 279- 284 ,(1998) , 10.1023/A:1006140513233
John M. Venditti, Robert A. Wesley, Jacqueline Plowman, Current NCI preclinical antitumor screening in vivo: results of tumor panel screening, 1976-1982, and future directions. Advances in pharmacology. ,vol. 20, pp. 1- 20 ,(1984) , 10.1016/S1054-3589(08)60263-X
Scudiero Da, Paull Kd, Abbott Bj, Shoemaker Rh, Monks A, Mayo Jg, Alley Mc, McLemore Tl, Boyd Mr, Fine Dl, Development of human tumor cell line panels for use in disease-oriented drug screening. Progress in Clinical and Biological Research. ,vol. 276, pp. 265- ,(1988)
Robert S. Kerbel, What is the optimal rodent model for anti-tumor drug testing? Cancer and Metastasis Reviews. ,vol. 17, pp. 301- 304 ,(1998) , 10.1023/A:1006152915959
Michael P. Rosenberg, Donna Bortner, Why transgenic and knockout animal models should be used (for drug efficacy studies in cancer) Cancer and Metastasis Reviews. ,vol. 17, pp. 295- 299 ,(1998) , 10.1023/A:1006196614142
E. Boven, H. H. Fiebig, S. Langdon, M. P. Dumont, Ø. Fodstad, B. J. M. Braakhuis, B. Winograd, D. P. Berger, Phase II preclinical drug screening in human tumor xenografts: a first European multicenter collaborative study. Cancer Research. ,vol. 52, pp. 5940- 5947 ,(1992)
Steven A. Rosenberg, Vincent T. DeVita, Samuel Hellman, Cancer : Principles and Practice of Oncology ,(1982)
S.P. Langdon, H.R. Hendriks, B.-J.M. Braakhuis, G. Pratesi, D.P. Berger, Ø. Fodstad, H.H. Fiebig, E. Boven, Preclinical phase II studies in human tumor xenografts: A European multicenter follow-up study Annals of Oncology. ,vol. 5, pp. 415- 422 ,(1994) , 10.1093/OXFORDJOURNALS.ANNONC.A058872
Michel Préfontaine, Julia T. Donovan, John L. Powell, Lynnette Buley, Treatment of refractory ovarian cancer with 5-fluorouracil and leucovorin. Gynecologic Oncology. ,vol. 61, pp. 249- 252 ,(1996) , 10.1006/GYNO.1996.0134